Претраживање
Приказ резултата 21-30 од 57
RY-023, an inverse agonist at alpha5 GABAA receptors: the influence on spatial memory and spontaneous locomotor activity
(Elsevier Science BV, Amsterdam, 2008)
Moclobemide dosage regimen adjustment in depressive patients on carbamazepine co-therapy
(Elsevier Science BV, Amsterdam, 2009)
Positive modulation at alpha(5)GABA(A) receptors is not beneficial for cognitive deficits induced by MK-801 in water maze in rats
(Elsevier Science BV, Amsterdam, 2014)
Acute effects of an inverse agonist selective for alpha(5) GABA(A) receptors on rat behaviour in the forced swim test
(Elsevier Science BV, Amsterdam, 2012)
PWZ-029 alleviates MK-801-induced memory deficits in the rat: implications for the treatment of cognitive impairment in schizophrenia
(Elsevier Science BV, Amsterdam, 2013)
MK-801-induced hyperlocomotion in rats is affected by modulation of alpha(5)-containing GABA(A) receptors
(Elsevier Science BV, Amsterdam, 2013)
Oxytocin affects changes in behaviour, BDNF and Ki-67 expression in hippocampus, caused by chronic corticosterone treatment
(Elsevier Science BV, Amsterdam, 2016)
Ketamine in a model of depression resistant to tricyclic antidepressants
(Elsevier Science BV, Amsterdam, 2019)
Chronic magnesium supplementation increases hippocampal neurogenesis and decreases proliferation in myocardium in ACTH-treated rats
(Elsevier Science BV, Amsterdam, 2017)
Attaining in vivo selectivity of positive modulation of a3 GABA-A receptors in rats: a hard task
(Elsevier Science BV, Amsterdam, 2016)